Concepedia

T E Mertz

TE

Statistics

Publications

8

Citations

285

H-Index

8

Active since

1980

Affiliations

Pfizer (United States)(Current)

T E Mertz is an author at Pfizer (United States) specializing in pharmacology, medicine, and cardiology.

Publications per year

1980–1998

8

Publications

8

Ischemic stroke: Relation of age, lesion location, and initial neurologic deficit to functional outcome

Stephen N. Macciocchi, Paul T. Diamond, Wayne M. Alves et al. · Archives of Physical Medicine and Rehabilitation · 1998 · 135 citations

, , +17

CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.

Thomas J. Steffe, T E Mertz, S. G. Hastings et al. · Journal of Pharmacology and Experimental Therapeutics · 1980 · 40 citations

, , +9

Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.

T E Mertz, Hamilton Kaplan · Journal of Pharmacology and Experimental Therapeutics · 1982 · 30 citations

, , +17

CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.

Harvey Kaplan, Daniel M. Cohen, Arnold D. Essenburg et al. · PubMed · 1984 · 21 citations

, , +8

Endothelin A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs.

T E Mertz, Thomas B. McClanahan, M. A. Flynn et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 17 citations

, , +12

1–5 of 8